Health Catalyst (NASDAQ:HCAT) Given New $4.00 Price Target at Evercore ISI

Health Catalyst (NASDAQ:HCAT) had its price target hoisted by Evercore ISI from $3.00 to $4.00 in a research report report published on Thursday morning,Benzinga reports. Evercore ISI currently has an in-line rating on the stock.

A number of other equities analysts have also commented on HCAT. BTIG Research lowered shares of Health Catalyst from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 17th. Citigroup downgraded shares of Health Catalyst from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $6.50 to $3.50 in a report on Friday, August 8th. Stifel Nicolaus cut their target price on shares of Health Catalyst from $5.50 to $4.50 and set a “hold” rating for the company in a research report on Friday, August 8th. Cantor Fitzgerald restated a “neutral” rating and set a $4.00 price target (down from $9.00) on shares of Health Catalyst in a report on Friday, August 8th. Finally, Piper Sandler lowered Health Catalyst from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $8.00 to $4.00 in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $5.82.

Health Catalyst Stock Performance

HCAT opened at $3.65 on Thursday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83. The company has a market cap of $256.87 million, a PE ratio of -2.42 and a beta of 1.46. The stock has a 50-day moving average of $3.63 and a 200-day moving average of $4.02. Health Catalyst has a 52-week low of $2.52 and a 52-week high of $9.24.

Hedge Funds Weigh In On Health Catalyst

Several large investors have recently added to or reduced their stakes in the company. Group One Trading LLC lifted its position in shares of Health Catalyst by 107.6% in the 4th quarter. Group One Trading LLC now owns 4,360 shares of the company’s stock worth $31,000 after acquiring an additional 2,260 shares during the period. Aquatic Capital Management LLC acquired a new position in shares of Health Catalyst in the fourth quarter valued at $63,000. Focus Partners Wealth bought a new position in Health Catalyst in the first quarter worth $46,000. Cresset Asset Management LLC bought a new position in Health Catalyst in the second quarter worth $39,000. Finally, Divergent Planning LLC acquired a new stake in Health Catalyst during the second quarter worth $45,000. Institutional investors and hedge funds own 85.00% of the company’s stock.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.